Revvity (RVTY) – Investment Analysts’ Weekly Ratings Updates

Revvity (NYSE: RVTY) recently received a number of ratings updates from brokerages and research firms:

• 5/13/2026 – Revvity was downgraded by Weiss Ratings from “sell (d+)” to “sell (d)”.
• 5/7/2026 – Revvity had its price target raised by Barclays PLC from $95.00 to $105.00. They now have an “equal weight” rating on the stock.
• 5/6/2026 – Revvity had its price target lowered by Stifel Nicolaus from $110.00 to $100.00. They now have a “hold” rating on the stock.
• 5/6/2026 – Revvity was given a new $117.00 price target by Robert W. Baird.
• 5/6/2026 – Revvity had its price target lowered by JPMorgan Chase & Co. from $96.00 to $90.00. They now have a “neutral” rating on the stock.
• 5/6/2026 – Revvity had its price target raised by TD Cowen from $115.00 to $120.00. They now have a “buy” rating on the stock.
• 5/4/2026 – Revvity had its price target lowered by Robert W. Baird from $129.00 to $125.00. They now have an “outperform” rating on the stock.
• 4/18/2026 – Revvity was downgraded by Wall Street Zen from “buy” to “hold”.
• 4/14/2026 – Revvity had its “equal weight” rating reaffirmed by Barclays PLC. They now have a $95.00 price target on the stock, down from $118.00.
• 4/14/2026 – Revvity was downgraded by Barclays PLC from “overweight” to “equal weight”. They now have a $95.00 price target on the stock, down from $118.00.
• 4/14/2026 – Revvity had its price target lowered by The Goldman Sachs Group, Inc. from $110.00 to $95.00. They now have a “neutral” rating on the stock.
• 3/31/2026 – Revvity had its price target lowered by JPMorgan Chase & Co. from $105.00 to $96.00. They now have a “neutral” rating on the stock.

Revvity Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Friday, July 17th will be issued a dividend of $0.07 per share. The ex-dividend date is Friday, July 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity’s payout ratio is currently 13.40%.

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.